DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20183471

Nipah virus in India: past, present and future

Prarthana M. S.

Abstract


Nipah virus (NiV) is one of the emerging highly pathogenic virus. Like Ebola and Zika viruses, NiV too is threatening the integrity of the mankind. The family Paramyxoviruses has been traditionally associated with a group of viruses with narrow host range and typically causes outbreaks with low mortality rates. But with the emergence of highly pathogenic Hendra virus and closely related NiV, they have evolved as a cause of fatal encephalitis across broad range of vertebrate species including humans. The natural reservoir of NiV is Pteropus bat, which is apparently distributed all over the South East Asia. The bat population from North East to North West states in India have NiV antibodies which mean there is active NiV infection among Indian bats. As NiV is associated with high morbidity and mortality they pose a risk from natural outbreaks, laboratory accidents or deliberate misuse. The development of effective prevention and treatment strategies is very crucial. Preparedness, surveillance, constant vigil needs to be carried out continuously in the country. The present outbreak in India after nearly eleven years with a high case fatality rate indicate that there is a total lack of health care systems preparedness and surveillance strategy. The anthropogenic and environmental changes occurring due to rapid urbanization and massive deforestation has made India now even more vulnerable for such recurrent outbreaks. This review highlights the changing trend of the NiV outbreaks in the past and the current outbreak in India.


Keywords


Nipah virus, Paramyxoviruses, Pteropus bat, Kozhikode

Full Text:

PDF

References


Luby SP. The pandemic potential of Nipah virus. Antiviral Res. 2013;100(1):38-43.

Lam CW, AbuBakar S, Chang LY. Identification of the cell binding domain in Nipah virus G glycoprotein using a phage display system. J Virological Methods. 2017;243:1-9.

Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet. 1999;354(9186):1257-9.

Virtue ER, Marsh GA, Wang LF. Paramyxoviruses infecting humans: the old, the new and the unknown. Future Microbiol. 2009;4(5):537-54.

Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, et al. Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet. 1999;354(9186):1253-6.

Vera-Velasco NM, García-Murria MJ, del Pino MM, Mingarro I, Martinez-Gil L. Proteomic composition of Nipah virus-like particles. J Proteomics. 2018;172:190-200.

Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, et al. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Scientific Rep. 2016;6:30916.

Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerging Infect Dis. 2006;12(2):235.

de Wit E, Munster VJ. Nipah Virus Emergence, Transmission, and Pathogenesis. In: Global Virology I-Identifying and Investigating Viral Diseases. Springer, New York, NY: 2015: 125-146.

Arankalle VA, Bandyopadhyay BT, Ramdasi AY, Jadi R, Patil DR, Rahman M, et al. Genomic characterization of nipah virus, west bengal, India. Emerging Infectious Dis. 2011;17(5):907.

Hariharan R. Fresh Nipah outbreak scare, schools, colleges to stay shut in Kozhikode till June 12: 10 points. Available at: https://www.ndtv.com/kerala-news/kerala-warns-of-second-wave-of-nipah-virus-killed-16-10-points-1861308?pfrom=home-topstories. Accessed on 05 October 2017.

Reuters. Nipah virus ourbreak: Two suspected cases of Nipah virus reported from Karnataka. The Times of India. Available at: https://timesofindia.indiatimes.com/india/two-suspected-cases-of-nipah-virus-reported-from-karnataka/articleshow/64285807.cms. Accessed on 05 May 2018.

Suri M. 10 Confirmed deaths from Nipah virus outbreak in India, including nurse treating patients. Available at: https://edition.cnn.com/2018/05/22/health/nipah-virus-death-toll-rises-intl/index.html. Accessed on 22 May 2018.

Xinhua. Bat infected well liked to 3rd outbreak of Nipah virus in India since 2001: officials. Asia and Pacific. Available at: http://www.xinhuanet.com/english/2018-05/23/c_137200667.htm. Accessed on 23 May 2018.

Angeletti S, Presti AL, Cella E, Ciccozzi M. Molecular epidemiology and phylogeny of nipah virus infection: a mini review. Asian Pacific J Tropical Med. 2016;9(7):630-4.

Kulkarni DD, Tosh C, Venkatesh G, Kumar DS. Nipah virus infection: current scenario. Indian J Virol. 2013;24(3):398-408.

Center for Disease control and Prevention. Nipah Virus (NiV). Available at: https://www.cdc.gov/vhf/nipah/. Accessed on 30 May 2018.

Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Current Opinion Virol. 2017;22:97-104.

Lam SK. Nipah virus—a potential agent of bioterrorism? Antiviral Res. 2003;57(1-2):113-9.

Sugai A, Sato H, Yoneda M, Kai C. Gene end-like sequences within the 3′ non-coding region of the Nipah virus genome attenuate viral gene transcription. Virology. 2017;508:36-44.

Bruhn JF, Barnett KC, Bibby J, Thomas JM, Keegan RM, Rigden DJ, et al. Crystal structure of the Nipah virus phosphoprotein tetramerization domain. J Virol. 2014;88(1):758-62.

Subramanian SK, Tey BT, Hamid M, Tan WS. Production of the matrix protein of Nipah virus in Escherichia coli: Virus-like particles and possible application for diagnosis. J Virological Methods. 2009;162(1-2):179-83.

Talekar A, Pessi A, Porotto M. Infection of primary neurons mediated by nipah virus envelope proteins: role of host target cells in antiviral action. J Virology. 2011;85(16):8422-6.

Erbar S, Maisner A. Nipah virus infection and glycoprotein targeting in endothelial cells. Virology J. 2010;7(1):305.

Bose S, Jardetzky TS, Lamb RA. Timing is everything: Fine-tuned molecular machines orchestrate paramyxovirus entry. Virology. 2015;479:518-31.

Wong JJ, Young TA, Zhang J, Liu S, Leser GP, Komives EA, et al. Monomeric ephrinB2 binding induces allosteric changes in Nipah virus G that precede its full activation. Nature Communications. 2017;8(1):781.

Dietzel E, Kolesnikova L, Sawatsky B, Heiner A, Weis M, Kobinger GP, et al. Nipah virus matrix protein influences fusogenicity and is essential for particle infectivity and stability. J Virol. 2016;90(5):2514-22.

Chadha MS, Comer JA, Lowe L, Rota PA, Rollin PE, Bellini WJ, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerging infectious diseases. 2006;12(2):235.

Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipahand Hendra virus infections. Microbes and infection. 2001;3(4):289-95.

Guillaume V, Lefeuvre A, Faure C, Marianneau P, Buckland R, Lam SK, et al. Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J Virol Methods. 2004;120(2):229-37.

Wacharapluesadee S, Hemachudha T. Duplex nested RT-PCR for detection of Nipah virus RNA from urine specimens of bats. J Virological Methods. 2007;141(1):97-101.

Kaku Y, Noguchi A, Marsh GA, Barr JA, Okutani A, Hotta K, et al. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J Virological Methods. 2012;179(1):226-32.

Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013;100(1):8-13.

Satterfield BA, Dawes BE, Milligan GN. Status of vaccine research and development of vaccines for Nipah virus. Vaccine. 2016;34(26):2971-5.

Kurup D, Wirblich C, Feldmann H, Marzi A, Schnell MJ. Rhabdovirus-based vaccine platforms against henipaviruses. J Virol. 2015;89(1):144-54.

Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC. Development and registration of recombinant veterinary vaccines: the example of the canarypox vector platform. Vaccine. 2007;25(30):5606-12.

Ploquin A, Szécsi J, Mathieu C, Guillaume V, Barateau V, Ong KC, et al. Protection against henipavirus infection by use of recombinant adeno-associated virus–vector vaccines. J Infectious Dis. 2012;207(3):469-78.

Afelt A, Lacroix A, Zawadzka-Pawlewska U, Pokojski W, Buchy P, Frutos R. Distribution of bat-borne viruses and environment patterns. Infection, Genetics Evolution. 2018;58:181-91.

Pang T. Vaccination in the third world. Contemporary issues. Comptes Rendus de l'Académie des Sciences-Series III-Sciences de la Vie. 1999;322(11):995-7.